Literature DB >> 14733934

Dipyridamole is neuroprotective for cultured rat embryonic cortical neurons.

Allan D Blake1.   

Abstract

The effects of a clinically useful cardiovascular agent, dipyridamole, were examined in a rodent tissue culture model of neuroprotection. Dipyridamole effectively protected rat embryonic day 18 (E18) cortical neurons from either 48 h trophic deprivation or 48 h exposure to the glutathione synthesis inhibitor, L-buthionine (R,S) sulfoximine. The neuron sparing actions of dipyridamole were time- and concentration-dependent and mimicked the actions of exogenously applied glutathione. These results demonstrate that dipyridamole protects primary neuronal cultures against either trophic or chemically mediated insults, and suggest that dipyridamole has a potent antioxidant ability that compensates for glutathione depletion in neuronal cultures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14733934     DOI: 10.1016/j.bbrc.2003.12.115

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Prior therapy with antiplatelet agents is not associated with outcome in patients with acute ischemic stroke/TIA.

Authors:  S Greisenegger; S Tentschert; M Weber; J Ferrari; W Lang; W Lalouschek
Journal:  J Neurol       Date:  2006-04-20       Impact factor: 4.849

Review 2.  Multifunctional actions of approved and candidate stroke drugs.

Authors:  Jens Minnerup; Wolf-Rüdiger Schäbitz
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

3.  Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.

Authors:  Hans-Christoph Diener; Ralph L Sacco; Salim Yusuf; Daniel Cotton; Stephanie Ounpuu; William A Lawton; Yuko Palesch; Reneé H Martin; Gregory W Albers; Philip Bath; Natan Bornstein; Bernard P L Chan; Sien-Tsong Chen; Luis Cunha; Björn Dahlöf; Jacques De Keyser; Geoffrey A Donnan; Conrado Estol; Philip Gorelick; Vivian Gu; Karin Hermansson; Lutz Hilbrich; Markku Kaste; Chuanzhen Lu; Thomas Machnig; Prem Pais; Robin Roberts; Veronika Skvortsova; Philip Teal; Danilo Toni; Cam VanderMaelen; Thor Voigt; Michael Weber; Byung-Woo Yoon
Journal:  Lancet Neurol       Date:  2008-08-29       Impact factor: 44.182

4.  The neuron-astrocyte-microglia triad in a rat model of chronic cerebral hypoperfusion: protective effect of dipyridamole.

Authors:  Daniele Lana; Alessia Melani; Anna Maria Pugliese; Sara Cipriani; Daniele Nosi; Felicita Pedata; Maria Grazia Giovannini
Journal:  Front Aging Neurosci       Date:  2014-11-27       Impact factor: 5.750

5.  Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients.

Authors:  Kholoud F Aliter; Rami A Al-Horani
Journal:  Curr Pharm Des       Date:  2021       Impact factor: 3.116

6.  Q134R: Small chemical compound with NFAT inhibitory properties improves behavioral performance and synapse function in mouse models of amyloid pathology.

Authors:  Pradoldej Sompol; Jenna L Gollihue; Susan D Kraner; Irina A Artiushin; Ryan A Cloyd; Emad A Chishti; Shon A Koren; Grant K Nation; Jose F Abisambra; Orsolya Huzian; Lajos I Nagy; Miklos Santha; Laszlo Hackler; Laszlo G Puskas; Christopher M Norris
Journal:  Aging Cell       Date:  2021-06-12       Impact factor: 9.304

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.